Trump pressures 17 pharma CEOs to cut US drug prices

1/8/2025 6:20

U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House said on Thursday.



Letters were sent to top executives at Eli Lilly, Sanofi, Regeneron, Merck & Co, Johnson & Johnson, and AstraZeneca, among others. Copies of the letters were posted on Trump's Truth Social account.



The president is calling on the companies to extend most favored nation pricing to Medicaid, guarantee such pricing for new drugs, and return excess overseas revenue to American patients and taxpayers, without providing details.



Trump has given the companies until September 29 to respond with binding commitments to those terms.